Corcept Therapeutics · 4 hours ago
Director, Pipeline and Portfolio Market Planning
Redwood City, CA
Full-time
Onsite
Director/Executive
$239K/yr - $281K/yr
8+ years expCorcept Therapeutics is at the forefront of developing cortisol modulators to treat serious diseases. The Director, Pipeline & Portfolio Market Planning will shape and drive product and portfolio strategies across clinical-stage programs, collaborating with various teams to ensure data-driven decisions that maximize the value of Corcept’s portfolio.
BiotechnologyMedicalPharmaceutical
No H1B
Responsibilities
Drive and influence program-level strategy initiatives to define product vision, optimize lifecycle value, and drive business impact
Provide physician, patient, and payer perspective in clinical strategy and new product planning
Design, implement, and continuously refine competitive intelligence and market analysis frameworks that proactively inform program decision-making
Independently lead integrated cross-functional teams, including Commercial, Medical, Development, and Research, to ensure alignment and strategic continuity across the product lifecycle
Develop, maintain, and communicate robust long-range revenue forecasts and valuation models to support program planning and resource allocation
Synthesize market research, competitive intelligence, and analytics into actionable insights to inform executive decision-making
Own the development and management of target product profiles (TPPs) for pipeline products, working with R&D teams to influence and support decisions
Lead asset assessments and contribute to business development diligence, guiding executive decision-making
Oversee and execute ad hoc cross-portfolio workstreams, including global expansion initiatives in partnership with Emerging Markets team
Model and promote Corcept’s key principles, collaborating effectively, embracing possibilities, following the data, and leading by doing, to build a culture of accountability, innovation, and trust
Qualification
Required
Applicants must be currently authorized to work in the United States on a full-time basis
Preferred
Proven ability to lead strategic planning initiatives across multiple therapeutic areas, integrating scientific, clinical, commercial, and regulatory perspectives
Deep understanding of the drug development process, spanning early through late-stage programs, with experience translating clinical insights into commercial strategy
Exceptional executive communication skills; adept at conveying insights and strategies to senior leadership through compelling storytelling
Strong market research and analytical acumen with the ability to translate data into compelling strategic recommendations
Skilled at operating effectively in a dynamic, matrixed environment, building alignment and influencing stakeholders across R&D, Commercial, Medical, Finance, and Executive functions
Proven ability to rapidly synthesize information from multiple internal and external sources
Occasional travel required for corporate and industry events
Bachelor's degree required. Advanced degree preferred (MBA, MSc, PhD, PharmD)
8-10 years in product planning preferred, with relevant professional experience in new product planning, commercial planning, program management, corporate development and/or healthcare strategy consulting considered
Experience within relevant therapeutic areas such as oncology, neurology and/or rare diseases preferred
Prior experience working as part of or leading cross-functional drug development teams strongly preferred
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Leadership Team
Roberto Vieira
President, Oncology
Yuan Xu
Associate Director, Statistical Programming
Recent News
Company data provided by crunchbase